U.S. STOCKS ON THE MOVE-Minerva Surgical, Jounce Therapeutics, Southwest Airlines

Lanvin group

28/12/2022 14:25

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
Wall Street's main indexes were set to open higher on Wednesday on optimism
around the unwinding of pandemic restrictions by China, though a surge in
COVID-19 cases in the world's second-largest economy kept investors on edge.
 .N 
    At 9:01 a.m. ET, Dow e-minis  1YMc1  were up 0.14% at 33,463. S&P 500
e-minis  ESc1  were up 0.12% at 3,859.5, while Nasdaq 100 e-minis  NQc1  were up
0.06% at 10,921.75.
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** MariaDB  MRDB.N , up 13.4%
 ** Atento SA  ATTO.N , up 12.3%
 ** Companhia Energetica de Minas Gerais  CIGc.N , up 11.1%
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Lanvin Group Holdings Ltd  LANV.N , down 11.5%
 ** Studio City International Holdings Ltd  MSC.N , down 10.8%
 ** Global Blue Group Holding Ltd  GB.N , down 8.6%
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Argo Blockchain  ARBKL.O , up 372.9%
 ** Hall of Fame Resort & Entertainment Co  HOFVW.O , up 150.0%
 ** Minerva Surgical Inc  UTRS.O , up 126.2%
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Powered Brands  POWRW.O , down 89.6%
 ** Sigma Additive Solutions Inc  SASI.O , down 57%
 ** Bridgetown Holdings Ltd  BTWNW.O , down 33.1%
 ** Southwest Airlines Co  LUV.N : down 1.4% premarket
 BUZZ - Down after flight cancellations draw scrutiny  urn:newsml:reuters.com:*:nL4N33I1IE
 ** Minerva Surgical Inc  UTRS.O : up 126.2% premarket
 BUZZ - Shares soar on $30 mln private placement  urn:newsml:reuters.com:*:nL4N33I1SK
 ** Jounce Therapeutics Inc  JNCE.O : up 70.9% premarket
 BUZZ - Soars as Gilead Sciences to buy cancer therapy rights  urn:newsml:reuters.com:*:nL4N33I1SL
 ** Minerva Neurosciences Inc  NERV.O : down 25.4% premarket
 BUZZ - Down as FDA refuses to review schizophrenia drug again  urn:newsml:reuters.com:*:nL4N33I1V7 
 (Compiled by Rajarshi Roy and Anne Florentyna Gnanaraja Sekar)
 ((AnneFlorentyna.GnanarajaSekar@thomsonreuters.com))